Document is current
Any future updates will be listed below
-
Authors
Valentini, Ilaria https://orcid.org/0000-0001-5940-7495
Ghetti, Gianni
Pane, Marika
Rumi, Filippo
Di Brino, Eugenio
Basile, Michele
Pistillo, Gabriele Maria
Bischof, Matthias
-
Funding
Funding for this research was provided by:
Novartis Gene Therapies (Novartis Gene Therapies)
- License Information
-
More Information
Article History
Received: 18 June 2024
Accepted: 10 June 2025
First Online: 26 June 2025
Declarations
:
: As no new studies with human participants were included in this analysis, Institutional Review Board approval was not required, patient consent to participate was not necessary, and the Declaration of Helsinki 1964 does not apply.
: Gianni Ghetti is an employee of AdRes HEOR s.r.l., which has received project funding from Novartis Gene Therapies, Inc./Novartis Pharma AG. Marika Pane was supported by Novartis for this study. Matthias Bischof is an employee of Novartis Pharma AG, Basel, Switzerland, and owns Novartis stock or other equities. Gabriele Maria Pistillo is an employee of Novartis Pharma AG, Basel, Switzerland, and owns Novartis stock or other equities. Filippo Rumi, Ilaria Valentini, Eugenio Di Brino, and Michele Basile do not have any conflicts of interest to disclose.
